My thought on $ADXS
I have been looking for ADXS action lately. Good swings if you have stomach for it.
Near-term target $1.20
Long term
The company has cash into 2022.
A few catalysts
Forthcoming Milestones
*ADXS-503: Phase 1/2 combination with KEYTRUDA--clinical and immune/biomarker data for KEYTRUDA failures as well as first-line patients
ADXS-504: Clinical trial initiation; initial data readout
ADXS-PSA: Announcement of next steps
The first patient dosed with HOT-Prostate by Q1 2021
Near-term target $1.20
Long term
The company has cash into 2022.
A few catalysts
- ADXS-HOT: Off-the-shelf, tumor type-specific constructs
ADXS-503 in NSCLC in Phase 1/2 study
ADXS-504 in prostate cancer scheduled to enter the clinic in Q1 2021
Forthcoming Milestones
*ADXS-503: Phase 1/2 combination with KEYTRUDA--clinical and immune/biomarker data for KEYTRUDA failures as well as first-line patients
ADXS-504: Clinical trial initiation; initial data readout
ADXS-PSA: Announcement of next steps
The first patient dosed with HOT-Prostate by Q1 2021
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.